Hot Flashes and Cardiovascular Disease Risk Indices Among Women With HIV
Mabel Toribio(Boston College), Markella V. Zanni(Harvard University), Sarah M Chu(Harvard University), Crystal M. North(Harvard University), Takara L. Stanley(Brigham and Women's Hospital), Magid Awadalla(Massachusetts General Hospital), Zsófia D. Drobni(Semmelweis University), Michael Jerosch‐Herold(Brigham and Women's Hospital), Sara E. Looby(Cancer Research And Biostatistics), Evelynne S. Fulda(Cancer Research And Biostatistics), Michael D. Nelson(The University of Texas at Arlington), Tricia H. Burdo(Temple University), Tomas G. Neilan(Albert Einstein College of Medicine), Lidia S. Szczepaniak(The University of Texas Southwestern Medical Center), Madeline Cetlin(Harvard University)
Cited by 4
Related Papers
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
|Journal of the American College of Cardiology|2018|1.5k
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
|New England Journal of Medicine|2020|1.4k
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and Lipodystrophy
|Clinical Infectious Diseases|2001|680
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589